Xsensio closes a $7M oversubscribed Series A and starts a long-term collaboration with Texas Instruments.Read the announcement

Real-time biochemical sensing, directly on the skin

Xsensio goes beyond physical activity tracking. The Lab-on-Skin™ chip analyses biomarkers in interstitial fluid and turns subtle physiological changes into continuous insight.

Researcher working at a microscope with a sensor sample in the laboratory

Interstitial fluid, the body's natural window

Interstitial fluid surrounds the cells of the body and reflects inflammation, metabolism and organ function. The Lab-on-Skin™ chip reads it continuously, combining nanotechnology, biochemistry and microfluidics.

All data is made securely available in real time to patients, caregivers or healthcare providers, enabling earlier interventions and more personalised care.

Semiconductors for high sensitivity and extreme miniaturisation

The sensing platform was developed at the Nanolab of the Swiss Federal Institute of Technology. Designed for multiparametric analysis, one ultra-miniaturised chip integrates several sensors, and its modular architecture adapts the same platform to different clinical use cases.

Metabolites

Part of the multiparametric range the chip is designed to cover.

Ions

Earlier research used ion-sensitive field-effect transistors with ultra-low-volume microfluidics.

Proteins

The platform spans metabolites and ions through to proteins and hormones on one configurable chip.

Hormones

The team has published an extended gate field-effect transistor for sensing the stress hormone cortisol.

Every solution combines four parts

For each clinical or wellness application, Xsensio develops a tailored analytics tool, independently or in partnership.

Multi-sensor chip

Customised for the application.

Skin interface

Proprietary to Xsensio.

Wireless link

On-demand or continuous data streaming.

Analytics

Raw sensor data turned into actionable insight.

Build an application on Lab-on-Skin™

Talk to the team about a clinical study, an industrial partnership or a new biomarker panel.

Contact Xsensio